Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma

FENO measurement identified the subgroup of subjects with SRA with persistent eosinophilia despite steroid therapy. Further studies are needed on the use of FENO to monitor response to therapy over time in subjects with SRA.